Stockreport

VTv Therapeutics: Cadisegliatin's Phase 3 CATT1 Readout Is The Next Catalyst [Seeking Alpha]

vTv Therapeutics Inc. - Class A  (VTVT) 
Last vtv therapeutics inc. - class a earnings: 7/31 04:30 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.vtvtherapeutics.com
PDF Cadisegliatin's Phase 2 SimpliciT-1 showed HbA1c improvement, fewer severe hypoglycemia events, and favorable safety. In my view, this positions the stock favorably a [Read more]